Interpreting Long-Term Outcomes From the CROWN Trial

Faculty review findings from the 7-year update of the CROWN trial and discuss how long-term efficacy data are informing the management of ALK-positive NSCLC. The panel examines outcomes related to progression-free survival, durability of response, and intracranial disease control, and considers how these findings contribute to current treatment discussions. The conversation explores patterns observed over extended follow-up and addresses how long-term data may help clinicians communicate treatment expectations with patients. Faculty also discuss differences in patient outcomes over time and consider factors that may influence long-term disease control. This segment focuses on the interpretation and application of mature clinical trial data within contemporary practice.